← Evidence map

ArticleDigestive diseases and sciences2026

Combining Guselkumab with Upadacitinib Is Safe and Effective in the Treatment of Medically Complex Inflammatory Bowel Disease.

Navneet Natt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 42240958